Back to VANGUARD GROUP INC

CPRX
6 quarters

Position history for VANGUARD GROUP INC's holdings in CATALYST PHARMACEUTICALS INC

VANGUARD GROUP INC holds 8.4M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $196.8M as of 2025-Q4. The position was decreased (-3.2% shares). CPRX represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$196.8M

Current Shares

8.4M

Total Value Change

+$37M

Total Shares Change

+391,269

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
8.4M
-3.2%
$196.8M0.0%$23.29
0
2025-Q3
Decreased
8.7M
-0.6%
$171.7M0.0%$19.55
0
2025-Q2
Increased
8.8M
+3.2%
$190.2M0.0%$21.78
31
2025-Q1
Increased
8.5M
+0.8%
$206M0.0%$24.69
31
2024-Q4
Increased
8.4M
+4.8%
$176M0.0%$21.07
32
2024-Q3
New
8M
-
$159.9M0.0%$19.56
42

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used